Diabetes News and Research

Latest Diabetes News and Research

Health and education leaders commend school for promoting physical activity among students

During a visit today to Conrad Weiser Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to increase physical activity among students.

22 Dec 2009

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Veolia Energy North America, a leading provider of sustainable energy services, management solutions, and facility operations is pleased to announce that it has entered into a long-term agreement to operate and maintain the Medical Area Total Energy Plant (MATEP) assets in the Longwood Medical Area of Boston.

22 Dec 2009

Genome-wide study of African and African-American ancestry released by scientists

People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.

22 Dec 2009

Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue

Regenerative medicine therapies often require the growth of functional, stable blood vessels at the site of an injury. Using synthetic polymers called hydrogels, researchers at the Georgia Institute of Technology have been able to induce significant vasculature growth in areas of damaged tissue.

22 Dec 2009

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.

22 Dec 2009

DMC launches Dental Optimizer, a free online application connected to Microsoft HealthVault

While politicians and pundits continue to arm wrestle the minutiae of health reform, more and more Americans are stepping up to take charge of their own health.

22 Dec 2009

Medical students from TCOM offer health screening for homeless

Medical students from the Texas College of Osteopathic Medicine (TCOM) offered a health screening for the homeless Friday, Dec. 11, in an effort to give back to the people of Tarrant County.

22 Dec 2009

Cost outweighs benefits of self-monitoring blood glucose test strips

Routine self-monitoring of blood glucose levels by people with type 2 diabetes who are not taking insulin is an ineffective use of health resources as the modest benefits are outweighed by the significant cost of test strips, suggest 2 studies http://www.cmaj.ca/embargo/cmaj091017.pdf and http://www.cmaj.ca/embargo/cmaj090765.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca .

22 Dec 2009

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Start 2010 right: consume more seafood omega-3 fatty acids. Improvements or lower risks in age-related macular degeneration (AMD), chronic kidney disease and heart health have been reported in people with higher intakes of fatty fish or the omega-3s they contain.

22 Dec 2009

Amylin Pharmaceuticals' modified exendins and exendin agonists patent: USPTO issues Final Office Action

ConjuChem Biotechnologies Inc. announced today that the U.S. Patent & Trademark Office (USPTO) has issued a Right of Appeal Notice (Final Office Action) in the inter partes reexamination of Patent No. 6,924,264. The patent, entitled "Modified Exendins and Exendin Agonists," was issued in August 2005 and is assigned to Amylin Pharmaceuticals, Inc. The Action once again rejected all the subject claims for obviousness and/or lack of novelty. The inter partes reexamination in the USPTO does not involve any of ConjuChem's patents.

22 Dec 2009

Reference platform for diabetic retinopathy and other vascular complications

The volume addresses a variety of current scientific discussions about mechanisms of damage such as growth factors and the VEGF/PEDF balance in the diabetic eye, the ocular renin-angiotensin system, and leukocyte interactions with the microvasculature among others.

22 Dec 2009

Jamie Oliver to receive the 2010 TED Prize

Jamie Oliver, celebrity chef and standard-bearer in the fight against obesity and other diet related issues, has been announced as the recipient of the 2010 TED Prize, an award granting recipients $100,000 and something much bigger - an opportunity to realize a wish to change the world.

22 Dec 2009

Discovery suggests how toxin-filtering cells go awry

Researchers from Children's Hospital Boston and Brigham and Women's Hospital have identified an important genetic cause of a devastating kidney disease that is the second leading cause of kidney failure in children, according to The NephCure Foundation.

22 Dec 2009

PDL BioPharma enters into non-exclusive license agreement with Eli Lilly

PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL's Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.

22 Dec 2009

While mortality from diabetes declines in Canada, the income-related mortality gap increases

While mortality from diabetes has declined in Canada, the income-related mortality gap is increasing, with lower income groups faring worse than higher income groups, according to a new studyhttp://www.cmaj.ca/embargo/cmaj090495.pdf in CMAJ ( Canadian Medical Association Journal) www.cmaj.ca.

22 Dec 2009

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

22 Dec 2009

Healthy Humans receives the 2009 Life Sciences Startup Company of the Year award

Healthy Humans (www.healthyhumans.com), an online wellness solutions company, received the 2009 Life Sciences Startup Company of the Year award from the Eastern Technology Council.

21 Dec 2009

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine Biosciences, Inc. today announced their highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor, NBI-98854, will be advanced in clinical development.

21 Dec 2009

ValueOptions employs TriZetto’s Clinical CareAdvance application

The TriZetto Group, Inc. today announced that ValueOptions® Inc., the nation’s largest independent behavioral healthcare and wellness company, recently went live with TriZetto’s Clinical CareAdvance® application 4.41 and expects to launch TriZetto’s Personal CareAdvance® application in early 2010.

21 Dec 2009

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company’s intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.

21 Dec 2009

Diabetes News and Research

Latest Diabetes News and Research

Health and education leaders commend school for promoting physical activity among students

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Genome-wide study of African and African-American ancestry released by scientists

Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue

ZEGERID OTC approval triggers $20M milestone payment to Santarus

DMC launches Dental Optimizer, a free online application connected to Microsoft HealthVault

Medical students from TCOM offer health screening for homeless

Cost outweighs benefits of self-monitoring blood glucose test strips

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Amylin Pharmaceuticals' modified exendins and exendin agonists patent: USPTO issues Final Office Action

Reference platform for diabetic retinopathy and other vascular complications

Jamie Oliver to receive the 2010 TED Prize

Discovery suggests how toxin-filtering cells go awry

PDL BioPharma enters into non-exclusive license agreement with Eli Lilly

While mortality from diabetes declines in Canada, the income-related mortality gap increases

Findings may help develop new antiviral drugs for influenza

Healthy Humans receives the 2009 Life Sciences Startup Company of the Year award

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

ValueOptions employs TriZetto’s Clinical CareAdvance application

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Diabetes News and Research

Latest Diabetes News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in